Enhancing Patient Safety Through Bleeding Risk Assessment
At Neftaly, patient safety and personalized care are top priorities. The HAS-BLED score is an essential clinical tool used to assess the risk of bleeding in patients who require anticoagulation therapy, particularly those with atrial fibrillation. By identifying patients at higher risk, healthcare providers can tailor treatments to balance the benefits of stroke prevention with bleeding safety.
What is the HAS-BLED Score?
The HAS-BLED score evaluates bleeding risk based on several clinical factors. Each factor scores one point, with higher total scores indicating greater bleeding risk.
The acronym stands for:
- H – Hypertension (uncontrolled, >160 mmHg)
- A – Abnormal renal and liver function (1 point each)
- S – Stroke history
- B – Bleeding history or predisposition
- L – Labile INR (if on warfarin)
- E – Elderly (age >65 years)
- D – Drugs (such as antiplatelets, NSAIDs) or alcohol use (1 point each)
Why is HAS-BLED Important?
- Risk Stratification: Helps clinicians identify patients at increased risk of major bleeding.
- Treatment Guidance: Informs decisions regarding anticoagulation therapy, monitoring frequency, and risk mitigation strategies.
- Improved Patient Outcomes: Enables proactive management to minimize bleeding complications while maintaining stroke prevention.
- Supports Shared Decision-Making: Facilitates informed discussions between clinicians and patients about therapy risks and benefits.
Neftaly’s Role in Promoting HAS-BLED Utilization
- Healthcare Provider Education
- Training clinicians to accurately calculate and interpret HAS-BLED scores.
- Patient Awareness
- Educating patients on bleeding risks and the importance of monitoring and lifestyle adjustments.
- Clinical Protocols and Tools
- Integrating HAS-BLED scoring into electronic health records and decision-support systems for streamlined care.
- Risk Mitigation Strategies
- Developing care plans that address modifiable risk factors identified by HAS-BLED.
Who Benefits from HAS-BLED Scoring?
- Patients on anticoagulant therapy, especially with atrial fibrillation
- Cardiologists, primary care physicians, and anticoagulation clinics
- Healthcare systems focused on reducing adverse events
- Patient education and support programs
Balancing Safety and Effectiveness in Anticoagulation
By incorporating the HAS-BLED score into clinical practice, Neftaly supports safer anticoagulation management, reducing bleeding complications without compromising stroke prevention. This personalized approach enhances overall cardiovascular care and patient quality of life.
